Aronia Berry Extract Modulates MYD88/NF-kB/P-Glycoprotein Axis to Overcome Gemcitabine Resistance in Pancreatic Cancer

• Главные авторы: Yuan Li (Автор), Caiming Xu (Автор), Haiyong Han (Автор), Silvia Pascual-Sabater (Автор), Cristina Fillat (Автор), Ajay Goel (Автор)
• Формат: ‌
• Опубликовано: MDPI AG, 2024-07-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal disease with poor survival rates, primarily due to the limited effectiveness of gemcitabine (Gem)-based chemotherapy, as well as the acquisition of chemotherapeutic resistance. Aronia berry extracts (ABEs), abundant in phenolic constituents,...